Literature DB >> 6435792

Psychotic reactions during treatment of pituitary tumours with dopamine agonists.

T H Turner, J C Cookson, J A Wass, P L Drury, P A Price, G M Besser.   

Abstract

Of 600 patients treated with the dopamine agonist drugs bromocriptine and lisuride for functioning pituitary tumours, eight developed drug related psychoses. Symptoms included auditory hallucinations, delusional ideas, and appreciable changes in mood. These reactions occurred with lower doses of the drugs than previously reported and remitted when treatment was stopped. The possibility of psychiatric side effects with dopamine agonist treatment should be recognised in view of the strain that may be placed on patients and their families.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6435792      PMCID: PMC1443261          DOI: 10.1136/bmj.289.6452.1101

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

Review 1.  Drug therapy: Bromocriptine.

Authors:  D Parkes
Journal:  N Engl J Med       Date:  1979-10-18       Impact factor: 91.245

2.  Treated mania exacerbated by bromocriptine.

Authors:  J M Johnson
Journal:  Am J Psychiatry       Date:  1981-07       Impact factor: 18.112

3.  Bromocriptine-induced mania?

Authors:  D N Vlissides; D Gill; J Castelow
Journal:  Br Med J       Date:  1978-02-25

4.  Successful treatment with pimozide of delusional parasitosis.

Authors:  T M Reilly; W H Jopling; A W Beard
Journal:  Br J Dermatol       Date:  1978-04       Impact factor: 9.302

5.  Bromocriptine-induced mania?

Authors:  N M Brook; I B Cookson
Journal:  Br Med J       Date:  1978-03-25

6.  Acromegaly and depression.

Authors:  A Margo
Journal:  Br J Psychiatry       Date:  1981-11       Impact factor: 9.319

7.  Mental disorders from low-dose bromocriptine.

Authors:  K C Pearson
Journal:  N Engl J Med       Date:  1981-07-16       Impact factor: 91.245

8.  Positive and negative schizophrenic symptoms and the role of dopamine.

Authors:  T J Crow
Journal:  Br J Psychiatry       Date:  1980-10       Impact factor: 9.319

9.  A dopaminergic mechanism in mania.

Authors:  R H Gerner; R M Post; W E Bunney
Journal:  Am J Psychiatry       Date:  1976-10       Impact factor: 18.112

10.  Long-term treatment of parkinsonism with bromocriptine.

Authors:  D B Calne; C Plotkin; A C Williams; J G Nutt; A Neophytides; P F Teychenne
Journal:  Lancet       Date:  1978-04-08       Impact factor: 79.321

View more
  13 in total

Review 1.  Medical management of prolactin-secreting pituitary adenomas.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

2.  Treatment of presumed prolactinoma by transsphenoidal operation: early and late results.

Authors:  J A Thomson; G M Teasdale; D Gordon; D C McCruden; D L Davies
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-30

Review 3.  Therapeutic applications of bromocriptine in endocrine and neurological diseases.

Authors:  K Y Ho; M O Thorner
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

4.  Bromocriptine and psychosis: a literature review.

Authors:  A Boyd
Journal:  Psychiatr Q       Date:  1995

Review 5.  Drug-induced psychiatric disorders and their management.

Authors:  L E Hollister
Journal:  Med Toxicol       Date:  1986 Nov-Dec

Review 6.  Drug-induced mania.

Authors:  M Peet; S Peters
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

Review 7.  Pharmacological therapy for acromegaly: a critical review.

Authors:  Alex F Muller; Aart Jan Van Der Lely
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 8.  Drug-induced mania in the elderly.

Authors:  L Ganzini; S B Millar; J R Walsh
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

Review 9.  Drug-induced mania--causative agents, clinical characteristics and management. A retrospective analysis of the literature.

Authors:  D L Sultzer; J L Cummings
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

Review 10.  Visual hallucinations in the differential diagnosis of parkinsonism.

Authors:  Kelly Bertram; David R Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-01-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.